Cells Power
Kintaro Cells Power is dedicated to advancing regenerative medicine through the development and production of KINTARO Cells®, highly specialized mesenchymal stem cells derived from bone marrow. The company aims to contribute to society by prolonging healthy lifespans, promoting scientific research, and expanding its global presence in the field of cellular therapeutics.
Industries
Nr. of Employees
small (1-50)
Products
Allogeneic bone marrow-derived mesenchymal stem cell product
Multipotent mesenchymal stem cells derived from bone marrow of screened young donors, cultured and expanded using patented culture technologies for regenerative-medicine applications.
Allogeneic bone marrow-derived mesenchymal stem cell product
Multipotent mesenchymal stem cells derived from bone marrow of screened young donors, cultured and expanded using patented culture technologies for regenerative-medicine applications.
Services
Provision of cultured allogeneic bone marrow-derived mesenchymal stem cell batches for clinical procedures and research use, with QC release criteria and cold-chain delivery.
Joint research collaborations with medical universities and international partners for preclinical and translational studies of MSCs and related biopharmaceutical development.
Advisory support for establishing GMP or GCTP-compliant cell production facilities and production-control systems aimed at clinical production scale-up.
Accreditation and hands-on training programs for medical doctors and clinical staff focused on clean-room procedures and administration of cell therapies.
Management and expansion of patents and trademarks for culture methods, media and transport processes across multiple jurisdictions.
Provision of cultured allogeneic bone marrow-derived mesenchymal stem cell batches for clinical procedures and research use, with QC release criteria and cold-chain delivery.
Joint research collaborations with medical universities and international partners for preclinical and translational studies of MSCs and related biopharmaceutical development.
Advisory support for establishing GMP or GCTP-compliant cell production facilities and production-control systems aimed at clinical production scale-up.
Accreditation and hands-on training programs for medical doctors and clinical staff focused on clean-room procedures and administration of cell therapies.
Management and expansion of patents and trademarks for culture methods, media and transport processes across multiple jurisdictions.
Expertise Areas
- Cell therapy manufacturing
- Bone marrow-derived MSC culture and scale-up
- Cryopreservation and cold-chain logistics for cell products
- Automated cell culture and robotics
Key Technologies
- Bone marrow-derived mesenchymal stem cell culture
- Donor screening and cell isolation
- Cell expansion and in vitro MSC propagation
- Cell culture media formulation and production
News & Updates
Announcement of the annual festival of the Cell Shrine in Otaru, Japan.
Seminar held with Mr. Takashi Otsuka, creator of symbiotic farming.
Participation in the 51st Oshoro Herring Fishing Association event.
Expansion of intellectual property registrations with new patents obtained.
Received the 2021 Global Excellence Award for Most Innovative Stem Cells Medical Supplier in Asia.
Announcement of the annual festival of the Cell Shrine in Otaru, Japan.
Seminar held with Mr. Takashi Otsuka, creator of symbiotic farming.
Participation in the 51st Oshoro Herring Fishing Association event.
Expansion of intellectual property registrations with new patents obtained.
Received the 2021 Global Excellence Award for Most Innovative Stem Cells Medical Supplier in Asia.